BioAtla Inc (BCAB) Stock: Uncovering 52-Week Market Trends

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. BioAtla Inc’s current trading price is -67.16% away from its 52-week high, while its distance from the 52-week low is 6.45%. The stock’s price range for this time frame has been between $1.24 and $4.02. The trading volume of the company’s shares in the Healthcare reached around 0.64 million for the day, which was evidently lower than the average daily volume of 0.82 million over the last three months.

BioAtla Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $4.02 on 04/04/24, and the lowest price during that time was $1.24, recorded on 10/27/23.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

How Financial Performance Impacts Market Capitalization

BioAtla Inc (BCAB) has experienced a quarterly decline of -66.33% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 63.52M and boasts a workforce of 65 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.4205, with a change in price of -1.4300. Similarly, BioAtla Inc recorded 706,889 in trading volume during the last 100 days, posting a change of -52.00%.

How BCAB’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for BCAB stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.01.

BCAB Stock Stochastic Average

The raw stochastic average for BioAtla Inc over the last 50 days is presently at 2.64%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 10.53%. Further, the company’s Stochastic %K and %D values for the last 20 days were 23.39% and 21.31%, respectively.

BCAB Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant loss of -46.34% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -46.12%. Over the past 30 days, the price of BCAB has leaped by -18.52%. And in the last five days, it has fallen by -10.20%.

Most Popular